BioAtla, Inc.
BCABOTCCIK 1826892HealthcareFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-05-1217:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000950170-21-000192 |
| 2021-04-3016:06 ET | DEF 14A | Proxy statementPeriod 2021-06-15 | 0001193125-21-144990 |
| 2021-03-2417:28 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001193125-21-092812 |
| 2021-02-0917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-034551 |
| 2020-12-2816:30 ET | SC 13D | Ownership report, active investor | 0001193125-20-327681 |
| 2020-12-1816:41 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-321571 |
| 2020-12-0916:03 ET | S-1/A | Registration statement, amended | 0001193125-20-313805 |
| 2020-12-0808:16 ET | S-1/A | Registration statement, amended | 0001193125-20-312311 |
| 2020-11-1317:31 ET | S-1 | Registration statement | 0001193125-20-293235 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 06:15 ET. Listed shows no prices and gives no investment advice.